Meeting Abstract

Riociguat for the treatment of inoperable CTEPH or persistent/recurrent PH after pulmonary endarterectomy (PEA): A responder analysis from the phase III CHEST-1 study


AutorenlisteD'Armini, Andrea M.; Ghofrani, Hossein-Ardeschir; Kim, Nick H.; Mayer, Eckhard; Simonneau, Gerald; Wilkins, Martin R.; Pulido, Tomas; Fritsch, Arno; Davie, Neil; Hoeper, Marius M.

Jahr der Veröffentlichung2013

ZeitschriftEuropean Respiratory Journal

Bandnummer42

ISSN0903-1936

eISSN1399-3003

VerlagEuropean Respiratory Society



Zitierstile

Harvard-ZitierstilD'Armini, A., Ghofrani, H., Kim, N., Mayer, E., Simonneau, G., Wilkins, M., et al. (2013) Riociguat for the treatment of inoperable CTEPH or persistent/recurrent PH after pulmonary endarterectomy (PEA): A responder analysis from the phase III CHEST-1 study, European Respiratory Journal, 42

APA-ZitierstilD'Armini, A., Ghofrani, H., Kim, N., Mayer, E., Simonneau, G., Wilkins, M., Pulido, T., Fritsch, A., Davie, N., & Hoeper, M. (2013). Riociguat for the treatment of inoperable CTEPH or persistent/recurrent PH after pulmonary endarterectomy (PEA): A responder analysis from the phase III CHEST-1 study. European Respiratory Journal. 42.



Schlagwörter


Pulmonary hypertensionTreatments

Zuletzt aktualisiert 2025-02-04 um 02:25